Sanara MedTech Inc. SMTI

SMTI Company Overview

Sanara MedTech Inc. is a U.S.-based medical technology company focused on advanced wound care, surgical products, and regenerative medicine solutions. The company operates within the broader healthcare and medical devices industries, primarily serving hospitals, surgical centers, wound care clinics, long-term care facilities, and healthcare practitioners. Sanara develops, markets, and distributes products intended to support chronic wound healing, surgical recovery, and skin repair, with revenue generated through both internally developed products and distribution partnerships.

The company’s principal business lines include advanced biologics, wound care products, collagen-based technologies, antimicrobial solutions, and surgical tissue products. Key offerings include products marketed under brands such as CellerateRX, BIAKŌS Antimicrobial Skin & Wound Cleanser, and regenerative tissue products obtained through affiliated investments and partnerships. Sanara has evolved from a wound care-focused company into a broader regenerative medicine platform through acquisitions, strategic investments, and commercialization agreements. Public filings and investor materials indicate that the company’s strategy emphasizes high-growth specialty wound care segments and clinician-focused product adoption.